CSRxP Leads Diverse Group Of Nearly 50 Organizations In Pledging Support For Bipartisan CREATES Act
Legislation Would Lower Prescription Drug Prices, Increase Competition,… Read More
© 2026 CSRXP- All Rights Reserved
What they’re Saying: Reactions to Congress’ Drug Pricing Hearings
On Tuesday, the U.S. House Oversight and Reform and Senate Finance Committees… Read More
CSRxP Statement on Trump Administration’s Latest Drug Pricing Proposal
For Immediate Release: Contact: Lauren Blair (201) 213-5004… Read More
THEY SAID IT! Drug Companies Have Been Warned
Drug Companies Have Been Warned: House & Senate Chairmen & Ranking… Read More
RealClearHealth: Path Forward To Solving Out-Of-Control Drug Prices
Meaningful Reforms Have Already Taken Shape – Now It’s Up To Congress And… Read More
Access To Drugs Is A Matter Of Life & Death, Mothers of Diabetic Children Testify Before Congress
At their first hearings of the 116th Congress, the Senate Finance and House… Read More
CSRxP Statement On House & Senate Committee Hearings On Skyrocketing Drug Prices
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
SHOT/CHASER: Pfizer & Novartis Double-Talk On Price Increases For Drugs Most Important To Bottom Lines
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More
CSRxP Applauds CMS’s Commitment To Lower Drug Prices
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today… Read More
“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part III
In advance of the House and Senate hearings on January 29, 2019… Read More
“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part II
In advance of the hearing on January 29, 2019, the Campaign for Sustainable Rx… Read More
“WHAT’S PAST IS PROLOGUE” Big Pharma’s Track Record Is A Vast Departure From Its Rhetoric: Part I
For Immediate Release: Contact: Lauren Blair (201) 213-5004 lblair@fp1strategies… Read More